Efficacy of Lactoferrin as an Adjunct Therapy in Patients With Hepatic Encephalopathy
Status:
Not yet recruiting
Trial end date:
2024-10-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate the efficacy of lactoferrin as an adjunct therapy in
improving clinical symptoms and laboratory indices in individuals with hepatic
encephalopathy.